StonvexLoading…
StonvexStonvexStonvexCore line items from BOW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $551.59M | $425.66M | $283.40M | $187.60M |
Operating Income | $67.30M | $50.53M | $32.12M | $14.66M |
Net Income | $53.79M | $38.24M | $25.05M | $11.26M |
EPS (Diluted) | $1.59 | $1.29 | $1.04 | $0.47 |
Total Assets | $2.37B | $1.65B | $1.03B | Not available |
Total Liabilities | $1.92B | $1.28B | $835.78M | Not available |
Cash & Equivalents | $193.54M | $97.48M | $118.07M | $64.66M |
Free Cash Flow OCF − CapEx | $326.02M | $291.18M | $232.41M | $177.67M |
Shares Outstanding | 32.78M | 32.66M | 24.00M | 24.00M |